Zoledronic acid injection is indicated for the treatment of hypercalcemia of malignancy and for the treatment of multiple ...

today announced it has launched Zoledronic Acid Injection, USP in the United States as a therapeutic generic equivalent for Zometa ® as approved by the U.S. Food and Drug Administration.

Zoledronic acid has several advantages over other bisphosphonates. In addition to having broader clinical utility, zoledronic acid can safely be infused over 15 minutes rather than the 2 hours ...

However it faces cheap competition from generics of Novartis’ older rival Zometa (zoledronic acid) and could itself lose patent protection around the end of the decade. Therefore Amgen will be ...

A proof-of-concept trial has shown that zoledronic acid is effective in preventing bone erosions in patients with early rheumatoid arthritis (RA). Zoledronic acid is a third-generation ...

Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.